Molecular characterization of the tumor microenvironment in breast cancer

被引:1062
作者
Allinen, M
Beroukhim, R
Cai, L
Brennan, C
Lahti-Domenici, J
Huang, HY
Porter, D
Hu, M
Chin, L
Richardson, A
Schnitt, S
Sellers, WR
Polyak, K [1 ]
机构
[1] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[2] Dana Farber Canc Inst, Dept Res Comp, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA
[5] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA
[6] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA
[7] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA
[8] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02115 USA
[9] Harvard Univ, Broad Inst, Cambridge, MA 02142 USA
[10] Harvard Univ, MIT, Cambridge, MA 02142 USA
关键词
D O I
10.1016/j.ccr.2004.06.010
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Here we describe the comprehensive gene expression profiles of each cell type composing normal breast tissue and in situ and invasive breast carcinomas using serial analysis of gene expression. Based on these data, we determined that extensive gene expression changes occur in all cell types during cancer progression and that a significant fraction of altered genes encode secreted proteins and receptors. Despite the dramatic gene expression changes in all cell types, genetic alterations were detected only in cancer epithelial cells. The CXCL14 and CXCL12 chemokines overexpressed in tumor myoepithelial cells and myofibroblasts, respectively, bind to receptors on epithelial cells and enhance their proliferation, migration, and invasion. Thus, chemokines may play a role in breast tumorigenesis by acting as paracrine factors.
引用
收藏
页码:17 / 32
页数:16
相关论文
共 95 条
  • [61] Porter DA, 2001, CANCER RES, V61, P5697
  • [62] Tumors are unique organs defined by abnormal signaling and context
    Radisky, D
    Hagios, C
    Bissell, MJ
    [J]. SEMINARS IN CANCER BIOLOGY, 2001, 11 (02) : 87 - 95
  • [63] The significance of unstable chromosomes in colorectal cancer
    Rajagopalan, H
    Nowak, MA
    Vogelstein, B
    Lengauer, C
    [J]. NATURE REVIEWS CANCER, 2003, 3 (09) : 695 - 701
  • [64] A molecular signature of metastasis in primary solid tumors
    Ramaswamy, S
    Ross, KN
    Lander, ES
    Golub, TR
    [J]. NATURE GENETICS, 2003, 33 (01) : 49 - 54
  • [65] Genetic heterogeneity of angiogenesis in mice
    Rohan, RM
    Fernandez, A
    Udagawa, T
    Wan, J
    D'Amato, RJ
    [J]. FASEB JOURNAL, 2000, 14 (07) : 871 - 876
  • [66] THE ORIGIN OF THE MYOFIBROBLASTS IN BREAST-CANCER - RECAPITULATION OF TUMOR ENVIRONMENT IN CULTURE UNRAVELS DIVERSITY AND IMPLICATES CONVERTED FIBROBLASTS AND RECRUITED SMOOTH
    RONNOVJESSEN, L
    PETERSEN, OW
    KOTELIANSKY, VE
    BISSELL, MJ
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (02) : 859 - 873
  • [67] Cellular changes involved in conversion of normal to malignant breast: Importance of the stromal reaction
    RonnovJessen, L
    Petersen, OW
    Bissell, MJ
    [J]. PHYSIOLOGICAL REVIEWS, 1996, 76 (01) : 69 - 125
  • [68] The biology of chemokines and their receptors
    Rossi, D
    Zlotnik, A
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 2000, 18 : 217 - 243
  • [69] A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors
    Rubin, JB
    Kung, AL
    Klein, RS
    Chan, JA
    Sun, YP
    Schmidt, K
    Kieran, MW
    Luster, AD
    Segal, RA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (23) : 13513 - 13518
  • [70] The Wnt pathway, epithelial-stromal interactions, and malignant progression in phyllodes tumours
    Sawyer, EJ
    Hanby, AM
    Rowan, AJ
    Gillett, CE
    Thomas, RE
    Poulsom, R
    Lakhani, SR
    Ellis, IO
    Ellis, P
    Tomlinson, IPM
    [J]. JOURNAL OF PATHOLOGY, 2002, 196 (04) : 437 - 444